Literature DB >> 18046769

Multistage designs in the genomic era: providing balance in complex disease studies.

Marie-Pierre Dubé1, Silke Schmidt, Elizabeth Hauser, Hatef Darabi, Jing Li, Amina Barhdadi, Xuexia Wang, Quiying Sha, Zhaogong Zhang, Tao Wang, Hugues Aschard, Mickael Guedj, Rori Rohlfs, Amy Anderson, Chelsea Taylor, Lucia Mirea, Radoslav Nickolov, Valentin Milanov, Hsin-Chao Yang, Yeunjoo Song, Ritwik Sinha.   

Abstract

In this summary paper, we describe the contributions included in the Multistage Design group (Group 14) at the Genetic Analysis Workshop 15, which was held during November 12-14, 2006. Our group contrasted and compared different approaches to reducing complexity in a genetic study through implementation of staged designs. Most groups used the simulated dataset (problem 3), which provided ample opportunities for evaluating various staged designs. A wide range of multistage designs that targeted different aspects of complexity were explored. We categorized these approaches as reducing phenotypic complexity, model complexity, analytic complexity or genetic complexity. In general we learned that: (1) when staged designs are carefully planned and implemented, the power loss compared to a single-stage analysis can be minimized and study cost is greatly reduced; (2) a joint analysis of the results from each stage is generally more powerful than treating the second stage as a replication analysis. (c) 2007 Wiley-Liss, Inc.

Mesh:

Year:  2007        PMID: 18046769      PMCID: PMC2582060          DOI: 10.1002/gepi.20288

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  23 in total

1.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

2.  Ordered subset analysis in genetic linkage mapping of complex traits.

Authors:  Elizabeth R Hauser; Richard M Watanabe; William L Duren; Meredyth P Bass; Carl D Langefeld; Michael Boehnke
Journal:  Genet Epidemiol       Date:  2004-07       Impact factor: 2.135

3.  Two-Stage sampling designs for gene association studies.

Authors:  Duncan Thomas; Rongrong Xie; Mulugeta Gebregziabher
Journal:  Genet Epidemiol       Date:  2004-12       Impact factor: 2.135

4.  Genome-wide strategies for detecting multiple loci that influence complex diseases.

Authors:  Jonathan Marchini; Peter Donnelly; Lon R Cardon
Journal:  Nat Genet       Date:  2005-03-27       Impact factor: 38.330

5.  Optimal two-stage genotyping designs for genome-wide association scans.

Authors:  Hansong Wang; Duncan C Thomas; Itsik Pe'er; Daniel O Stram
Journal:  Genet Epidemiol       Date:  2006-05       Impact factor: 2.135

6.  Efficient strategies for genome scanning using maximum-likelihood affected-sib-pair analysis.

Authors:  P Holmans; N Craddock
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  A two-step multiple-marker strategy for genome-wide association studies.

Authors:  Hugues Aschard; Mickaël Guedj; Florence Demenais
Journal:  BMC Proc       Date:  2007-12-18

8.  Two-stage strategies to detect gene x gene interactions in case-control data.

Authors:  Amina Barhdadi; Marie-Pierre Dubé
Journal:  BMC Proc       Date:  2007-12-18

9.  Two-stage analysis strategy for identifying the IgM quantitative trait locus.

Authors:  Tao Wang; Qing Lu; Monica Torres-Caban; Robert C Elston
Journal:  BMC Proc       Date:  2007-12-18

10.  Marker selection for whole-genome association studies with two-stage designs using dense single-nucleotide polymorphisms.

Authors:  Jing Li
Journal:  BMC Proc       Date:  2007-12-18
View more
  3 in total

1.  Effectiveness of strategies to increase the validity of findings from association studies: size vs. replication.

Authors:  Rolf Weitkunat; Etienne Kaelin; Grégory Vuillaume; Gerd Kallischnigg
Journal:  BMC Med Res Methodol       Date:  2010-05-28       Impact factor: 4.615

2.  Cuckoo search epistasis: a new method for exploring significant genetic interactions.

Authors:  M Aflakparast; H Salimi; A Gerami; M-P Dubé; S Visweswaran; A Masoudi-Nejad
Journal:  Heredity (Edinb)       Date:  2014-02-19       Impact factor: 3.821

3.  GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.

Authors:  Carlos Cruchaga; John S K Kauwe; Oscar Harari; Sheng Chih Jin; Yefei Cai; Celeste M Karch; Bruno A Benitez; Amanda T Jeng; Tara Skorupa; David Carrell; Sarah Bertelsen; Matthew Bailey; David McKean; Joshua M Shulman; Philip L De Jager; Lori Chibnik; David A Bennett; Steve E Arnold; Denise Harold; Rebecca Sims; Amy Gerrish; Julie Williams; Vivianna M Van Deerlin; Virginia M-Y Lee; Leslie M Shaw; John Q Trojanowski; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg; Elaine R Peskind; Douglas Galasko; Anne M Fagan; David M Holtzman; John C Morris; Alison M Goate
Journal:  Neuron       Date:  2013-04-04       Impact factor: 17.173

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.